Dezerv

Fund Overview

Fund Size

Fund Size

₹141 Cr

Expense Ratio

Expense Ratio

0.49%

ISIN

ISIN

INF754K01LV5

Minimum SIP

Minimum SIP

₹100

Exit Load

Exit Load

No Charges

Inception Date

Inception Date

26 Oct 2020

About this fund

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is a Index Funds mutual fund schemes offered by Edelweiss Mutual Fund. This fund has been in existence for 3 years, 6 months and 24 days, having been launched on 26-Oct-20.
As of 17-May-24, it has a Net Asset Value (NAV) of ₹17.51, Assets Under Management (AUM) of 140.89 Crores, and an expense ratio of 0.49%.
  • Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has given a CAGR return of 17.07% since inception.
  • The fund's asset allocation comprises around 99.99% in equities, 0.00% in debts, and 0.01% in cash & cash equivalents.
  • You can start investing in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+41.58%

(Cat Avg.)

3 Years

+13.62%

(Cat Avg.)

Since Inception

+17.07%

(Cat Avg.)

Portfolio Summaryas of 30th April 2024

Equity140.88 Cr99.99%
Others0.01 Cr0.01%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity19.41 Cr13.78%
Cipla LtdEquity9.89 Cr7.02%
Dr Reddy's Laboratories LtdEquity9.76 Cr6.92%
Max Healthcare Institute Ltd Ordinary SharesEquity8.8 Cr6.24%
Apollo Hospitals Enterprise LtdEquity8.06 Cr5.72%
Eli Lilly and CoEquity7.06 Cr5.01%
Divi's Laboratories LtdEquity6.44 Cr4.57%
Lupin LtdEquity5.05 Cr3.58%
Novo Nordisk A/S ADREquity4.43 Cr3.14%
Aurobindo Pharma LtdEquity4.1 Cr2.91%
Johnson & JohnsonEquity3.89 Cr2.76%
Merck & Co IncEquity3.66 Cr2.60%
Torrent Pharmaceuticals LtdEquity3.61 Cr2.56%
AbbVie IncEquity3.21 Cr2.28%
Fortis Healthcare LtdEquity2.68 Cr1.90%
Ipca Laboratories LtdEquity2.52 Cr1.79%
Thermo Fisher Scientific IncEquity2.46 Cr1.75%
Novartis AG ADREquity2.23 Cr1.58%
Laurus Labs LtdEquity2.12 Cr1.51%
Abbott LaboratoriesEquity2.06 Cr1.46%
Glenmark Pharmaceuticals LtdEquity2.01 Cr1.43%
Danaher CorpEquity1.94 Cr1.37%
J.B. Chemicals & Pharmaceuticals LtdEquity1.79 Cr1.27%
Biocon LtdEquity1.68 Cr1.19%
Syngene International LtdEquity1.67 Cr1.19%
Amgen IncEquity1.64 Cr1.16%
Global Health LtdEquity1.57 Cr1.11%
Intuitive Surgical IncEquity1.46 Cr1.04%
Gland Pharma LtdEquity1.33 Cr0.94%
Ajanta Pharma LtdEquity1.32 Cr0.93%
Stryker CorpEquity1.29 Cr0.92%
Narayana Hrudayalaya LtdEquity1.23 Cr0.87%
Dr. Lal PathLabs LtdEquity1.2 Cr0.85%
Medtronic PLCEquity1.19 Cr0.85%
GlaxoSmithKline Pharmaceuticals LtdEquity1.19 Cr0.84%
Vertex Pharmaceuticals IncEquity1.14 Cr0.81%
Gilead Sciences IncEquity0.91 Cr0.64%
Suven Pharmaceuticals LtdEquity0.91 Cr0.64%
Sanofi India LtdEquity0.91 Cr0.64%
Pfizer LtdEquity0.79 Cr0.56%
Becton Dickinson & CoEquity0.76 Cr0.54%
IQVIA Holdings IncEquity0.47 Cr0.34%
Agilent Technologies IncEquity0.45 Cr0.32%
Moderna IncEquity0.4 Cr0.28%
Illumina IncEquity0.22 Cr0.16%
Clearing Corporation Of India Ltd.Cash - Repurchase Agreement0.15 Cr0.11%
Net Receivables/(Payables)Cash - Collateral-0.14 Cr0.10%
Accrued InterestCash - Collateral0 Cr0.00%

Allocation By Market Cap (Equity)

Large Cap Stocks

68.49%

Mid Cap Stocks

23.75%

Small Cap Stocks

7.76%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare140.88 Cr99.99%

Risk & Performance Ratios

Standard Deviation

This fund

13.17%

Cat. avg.

--

Lower the better

Sharpe Ratio

This fund

0.65

Cat. avg.

--

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

--

Higher the better

Fund Managers

BJ

Bhavesh Jain

Since October 2021

Amit Vora

Amit Vora

Since February 2021

Additional Scheme Detailsas of 30th April 2024

ISININF754K01LV5Expense Ratio0.49%Exit LoadNo ChargesFund Size₹141 CrAge26 Oct 2020Lumpsum Minimum₹100Fund StatusOpen Ended Investment CompanyBenchmarkMSCI Ind Dom & Wld HealthC 45 NR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Index Funds Funds

Fund nameExpense RatioExit LoadFund size
1Y
ICICI Prudential Nifty Midcap 150 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹399.16 Cr56.7%
ICICI Prudential Nifty Midcap 150 Index Fund Regular Growth

Very High Risk

0.9%0.0%₹399.16 Cr55.7%
ICICI Prudential Nifty 200 Momentum 30 Index Fund Regular Growth

Very High Risk

1.0%0.0%₹156.71 Cr67.9%
SBI Nifty Midcap 150 Index Fund Regular Growth

Very High Risk

1.0%0.0%₹400.29 Cr56.1%
DSP Nifty 50 Equal Weight Index Fund Regular Growth

Very High Risk

1.0%0.0%₹1345.87 Cr35.9%
SBI Nifty Smallcap 250 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹711.53 Cr62.5%
SBI Nifty Midcap 150 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹400.29 Cr57.0%
ICICI Prudential Nifty 200 Momentum 30 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹156.71 Cr69.0%
DSP Nifty 50 Equal Weight Index Fund Direct Growth

Very High Risk

0.4%0.0%₹1345.87 Cr36.7%
SBI Nifty Smallcap 250 Index Fund Regular Growth

Very High Risk

1.0%0.0%₹711.53 Cr61.6%

About the AMC

Total AUM

₹1,48,645 Cr

Address

J.P.Morgan Tower, Mumbai, 400 098

Other Funds by Edelweiss Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
Edelweiss Multi Cap Fund Direct Growth

Very High Risk

0.4%1.0%₹1787.90 Cr-
Edelweiss Banking and PSU Debt Fund Direct Growth

Moderate Risk

0.4%0.0%₹284.54 Cr6.2%
Edelweiss NIFTY Large Midcap 250 Index Fund Direct Growth

Very High Risk

0.1%0.0%₹142.34 Cr43.6%
Edelweiss Money Market Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹485.28 Cr7.4%
Edelweiss Liquid Fund Direct Growth

Moderate Risk

0.1%0.0%₹4528.41 Cr7.4%
Edelweiss Mid Cap Fund Direct Growth

Very High Risk

0.4%1.0%₹5534.33 Cr54.7%
Edelweiss Greater China Equity Direct Growth

Very High Risk

1.4%1.0%₹1251.71 Cr3.5%
Edelweiss ASEAN Equity Off Shore Direct Growth

Very High Risk

1.6%1.0%₹60.15 Cr2.8%
Edelweiss Large & Mid Cap Fund Direct Growth

Very High Risk

0.5%1.0%₹2973.90 Cr40.3%
Edelweiss CRISIL PSU Plus SDL 50:50 Oct 2025 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹845.82 Cr6.9%
Edelweiss Europe Dynamic Equity Offshore Fund Direct Growth

Very High Risk

1.5%1.0%₹80.59 Cr19.6%
BHARAT Bond FOF April 2030 Direct Growth

Moderate Risk

0.1%0.0%₹6773.12 Cr6.5%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Fund Direct Growth

Moderate Risk

0.2%0.0%₹173.02 Cr6.6%
Edelweiss Flexi Cap Fund Direct Growth

Very High Risk

0.5%1.0%₹1784.41 Cr43.2%
Edelweiss Overnight Fund Direct Growth

Low Risk

0.1%0.0%₹417.32 Cr6.8%
Edelweiss Multi Asset Allocation Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹796.16 Cr-
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Very High Risk

0.5%0.0%₹140.89 Cr41.6%
Edelweiss Long Term Equity Fund Direct Growth

Very High Risk

0.7%0.0%₹342.70 Cr36.1%
Edelweiss Recently Listed IPO Fund Direct Growth

Very High Risk

1.0%2.0%₹932.05 Cr41.8%
Edelweiss Balanced Advantage Fund Direct Growth

Very High Risk

0.5%1.0%₹11135.73 Cr27.0%
Edelweiss Government Securities Fund Direct Growth

Moderate Risk

0.5%0.0%₹143.56 Cr7.6%
Edelweiss Small Cap Fund Direct Growth

Very High Risk

0.4%1.0%₹3361.40 Cr49.0%
Edelweiss Nifty Smallcap 250 Index Fund Direct Growth

Very High Risk

0.1%0.0%₹38.25 Cr62.9%
Edelweiss Nifty Midcap150 Momentum 50 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹215.78 Cr75.6%
Edelweiss Nifty Next 50 Index Fund Direct Growth

Very High Risk

0.1%0.0%₹25.87 Cr64.8%
Edelweiss Large Cap Fund Direct Growth

Very High Risk

0.7%1.0%₹874.24 Cr34.1%
Edelweiss Aggressive Hybrid Fund Direct Growth

Very High Risk

0.3%1.0%₹1564.25 Cr35.4%
Edelweiss Focused Equity Fund Direct Growth

Very High Risk

0.7%1.0%₹753.24 Cr38.9%
Edelweiss Nifty PSU Bond Plus SDL Apr 2027 50:50 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹3218.01 Cr6.7%
BHARAT Bond FOF April 2025 Direct Growth

Low to Moderate Risk

0.1%0.0%₹4964.02 Cr7.0%
BHARAT Bond FOF April 2031 Direct Growth

Moderate Risk

0.1%0.0%₹4524.46 Cr6.1%
Edelweiss Arbitrage Fund Direct Growth

Low Risk

0.4%0.0%₹10242.64 Cr8.5%
Edelweiss Emerging Markets Opportunities Equity Offshore Direct Growth

Very High Risk

1.4%1.0%₹111.98 Cr15.8%
Edelweiss US Technology Equity Fund of Fund Direct Growth

Very High Risk

1.4%1.0%₹2152.90 Cr49.8%
BHARAT Bond ETF FOF - April 2033 Direct Growth

Moderate Risk

0.1%0.0%₹2111.36 Cr6.5%
Edelweiss Gold and Silver ETF Fund of Fund Direct Growth

Very High Risk

0.4%0.0%₹86.50 Cr18.3%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL June 2027 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹92.38 Cr6.5%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Short Duration Index Fund Direct Growth

Moderate Risk

0.2%0.0%₹148.24 Cr6.8%
Edelweiss Nifty 50 Index Fund Direct Growth

Very High Risk

0.1%0.0%₹56.67 Cr24.6%
Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth

Very High Risk

0.1%0.0%₹28.41 Cr31.5%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund Direct Growth

Moderate Risk

0.2%0.0%₹943.06 Cr6.6%
BHARAT Bond ETF FOF - April 2032 Direct Growth

Moderate Risk

0.1%0.0%₹4324.04 Cr6.4%
Edelweiss Nifty PSU Bond Plus SDL Apr 2026 50:50 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹10028.02 Cr6.9%
Edelweiss US Value Equity Offshore Fund Direct Growth

Very High Risk

1.4%1.0%₹101.38 Cr21.8%
Edelweiss Equity Savings Fund Direct Growth

Moderate Risk

0.6%0.0%₹389.20 Cr17.4%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth, as of 17-May-2024, is ₹17.51.
The fund has generated 41.58% over the last 1 year and 13.62% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 99.99% in equities, 0.00% in bonds, and 0.01% in cash and cash equivalents.
The fund managers responsible for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth are:-
  1. Bhavesh Jain
  2. Amit Vora